Christopher Wilson

CNR de la Résistance aux Antibiotiques — France

Medicine · Health Sciences

56h-index16.8kcitations151works9.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(13), Immune Cell Function and Interaction(12), Epigenetics and DNA Methylation(11), CRISPR and Genetic Engineering(10), RNA modifications and cancer(10)

Publications150 total

An Investigation of Surgical Site Infections with Serratia marcescens
American Journal of Infection Control·2024
Vector integration and fate in the hemophilia dog liver multiple years after AAV-FVIII gene transfer
Blood·2024· 18 citedOpen Access
Determining trends of respiratory tract infections in a long-term care facility pilot surveillance project
Antimicrobial Stewardship & Healthcare Epidemiology·2023Open Access
Committees
2023Open Access
Outcomes for TAD/SLNB compared to ANC in node positive patients following neoadjuvant chemotherapy
European Journal of Surgical Oncology·2023
Magseed localised TAD for node positive patients following neoadjuvant chemotherapy in Glasgow
European Journal of Surgical Oncology·2023
Data from Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials
2023Open Access
Data from Characterization of the Mechanism of Action of the Pan Class I PI3K Inhibitor NVP-BKM120 across a Broad Range of Concentrations
2023Open Access
Data from Characterization of the Mechanism of Action of the Pan Class I PI3K Inhibitor NVP-BKM120 across a Broad Range of Concentrations
2023Open Access
Supplementary Methods, Table 1, and Figure Legends from Characterization of the Mechanism of Action of the Pan Class I PI3K Inhibitor NVP-BKM120 across a Broad Range of Concentrations
2023Open Access
Supplementary Figure 5 from Characterization of the Mechanism of Action of the Pan Class I PI3K Inhibitor NVP-BKM120 across a Broad Range of Concentrations
2023Open Access
Supplementary Figure 2 from Characterization of the Mechanism of Action of the Pan Class I PI3K Inhibitor NVP-BKM120 across a Broad Range of Concentrations
2023Open Access
Supplementary Figure 1 from Characterization of the Mechanism of Action of the Pan Class I PI3K Inhibitor NVP-BKM120 across a Broad Range of Concentrations
2023Open Access
Supplementary Figure 4 from Characterization of the Mechanism of Action of the Pan Class I PI3K Inhibitor NVP-BKM120 across a Broad Range of Concentrations
2023Open Access
Supplementary Figure 3 from Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials
2023Open Access
Supplementary Figure 1 from Characterization of the Mechanism of Action of the Pan Class I PI3K Inhibitor NVP-BKM120 across a Broad Range of Concentrations
2023Open Access
Data from Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials
2023Open Access
Supplementary Figure 3 from Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials
2023Open Access
Supplementary Methods, Table 1, and Figure Legends from Characterization of the Mechanism of Action of the Pan Class I PI3K Inhibitor NVP-BKM120 across a Broad Range of Concentrations
2023Open Access
Supplementary Figure 7 from Characterization of the Mechanism of Action of the Pan Class I PI3K Inhibitor NVP-BKM120 across a Broad Range of Concentrations
2023Open Access
page 1 of 8Next →

Frequent Co-authors

David R. Liu(8), Luke W. Koblan(5), Gregory A. Newby(5), David Fitzpatrick(5), William M. Weaver(5), Jonathan M. Levy(4), Roger M. Perlmutter(4), Peggy P. Lee(3), Karen W. Makar(3), Mercedes Pérez‐Melgosa(3), Maria Shnyreva(3), Mark A. Kay(3), Roman V. Agafonov(3), Dorothee Kern(3), Adeline M. Hajjar(3), Peter J. Chen(2), Aditya Raguram(2), Caroline Beard(2), Marianne T. Sweetser(2), B W. Thuronyi(2)